Order Article Reprints

Najimi M, Michel S, Binda MM, Gellynck K, Belmonte N, Mazza G, Gordillo N, Vainilovich Y, Sokal E. Human Allogeneic Liver-Derived Progenitor Cells Significantly Improve NAFLD Activity Score and Fibrosis in Late-Stage NASH Animal Model. Cells. 2022; 11(18):2854. https://doi.org/10.3390/cells11182854

Najimi, Mustapha, Sébastien Michel, Maria M. Binda, Kris Gellynck, Nathalie Belmonte, Giuseppe Mazza, Noelia Gordillo, Yelena Vainilovich, and Etienne Sokal. 2022. "Human Allogeneic Liver-Derived Progenitor Cells Significantly Improve NAFLD Activity Score and Fibrosis in Late-Stage NASH Animal Model" Cells 11, no. 18: 2854. https://doi.org/10.3390/cells11182854

Najimi, M., Michel, S., Binda, M. M., Gellynck, K., Belmonte, N., Mazza, G., Gordillo, N., Vainilovich, Y., & Sokal, E. (2022). Human Allogeneic Liver-Derived Progenitor Cells Significantly Improve NAFLD Activity Score and Fibrosis in Late-Stage NASH Animal Model. Cells, 11(18), 2854. https://doi.org/10.3390/cells11182854